The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Zarogoulidis, P., Tsakiridis K., & Zarogoulidis K. (2013).  Lung cancer: an update on current and future diagnostic and treatment techniques.. J Thorac Dis. 5 Suppl 4, S341.
Zarogoulidis, P., Tryfon S., Sapalidis K., Tsakiridis K., Baka S., Huang H., et al. (2020).  Bronchial HPV; the good the bad and the unknown.. Respir Med Case Rep. 30, 101053.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sahpatzidou D., Freitag L., Sakkas L., et al. (2014).  A gene therapy induced emphysema model and the protective role of stem cells.. Diagn Pathol. 9, 195.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Porpodis K., Kallianos A., et al. (2018).  A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.. Respir Med Case Rep. 23, 38-42.
Zarogoulidis, P., Lampaki S., Yarmus L., Kioumis I., Pitsiou G., Katsikogiannis N., et al. (2014).  Interleukin-7 and interleukin-15 for cancer.. J Cancer. 5(9), 765-73.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Zarogoulidis, P., Athanasiou E., Tsiouda T., Hatzibougias D., Huang H., Bai C., et al. (2017).  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.. Respir Med Case Rep. 22, 197-202.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. Expert Review of Respiratory Medicine. 1375(121), 1153 - 1159.
Zarogoulidis, P., Cheva A., Zarampouka K., Huang H., Li C., Huang Y., et al. (2013).  Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition.. J Thorac Dis. 5(3), 349-52.
Zarogoulidis, P., Glaros D., Kioumis I., Terzi E., Porpodis K., Tsiotsios A., et al. (2012).  Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.. Int J Gen Med. 5, 675-82.
Zarogoulidis, P., Lampaki S., J Turner F., Huang H., Kakolyris S., Syrigos K., et al. (2014).  mTOR pathway: A current, up-to-date mini-review (Review).. Oncol Lett. 8(6), 2367-2370.
Zarogoulidis, P., Kontakiotis T., Tsakiridis K., Karanikas M., Simoglou C., Porpodis K., et al. (2012).  Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review.. Ther Clin Risk Manag. 8, 279-86.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Zarogoulidis, K., Porpodis K., Domvri K., Eleftheriadou E., Ioannidou D., & Zarogoulidis P. (2016).  Diagnosing and treating pancoast tumors.. Expert Rev Respir Med. 10(12), 1255-1258.
Zarogoulidis, P., Kioumis I., Pitsiou G., Porpodis K., Lampaki S., Papaiwannou A., et al. (2014).  Pneumothorax: from definition to diagnosis and treatment.. J Thorac Dis. 6(Suppl 4), S372-6.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Zarogoulidis, P., Laskou S., Katsaounis A., Pavlidis E., Giannakidis D., Koulouris C., et al. (2018).  Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS).. Respir Med Case Rep. 24, 95-97.
Zarogoulidis, P., Tsakiridis K., Karapantzou C., Lampaki S., Kioumis I., Pitsiou G., et al. (2015).  Use of proteins as biomarkers and their role in carcinogenesis.. J Cancer. 6(1), 9-18.
Zarogoulidis, P., Hohenforst-Schmidt W., Darwiche K., Krauss L., Sparopoulou D., Sakkas L., et al. (2013).  2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.. Gene Ther. 20(10), 1022-8.
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.
Zarogoulidis, P., Constantinidis T., Steiropoulos P., Papanas N., Zarogoulidis K., & Maltezos E. (2011).  Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?. BMC Res Notes. 4, 4.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.